These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 8173185

  • 1. [In vitro characterization of S9788, a new modulator of multidrug resistance].
    Pérez V, Pierré A, Léonce S, Anstett M, Prost JF, Atassi G.
    Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185
    [Abstract] [Full Text] [Related]

  • 2. Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin.
    Pérez V, Pierré A, Léonce S, Anstett M, Atassi G.
    Anticancer Res; 1993 Apr; 13(4):985-90. PubMed ID: 8352569
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacological properties of S9788, a new modulator of multidrug resistance].
    Bull Cancer; 1994 Feb; 81(2):93-103. PubMed ID: 7894124
    [Abstract] [Full Text] [Related]

  • 4. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S, Pierré A, Anstett M, Pérez V, Genton A, Bizzari JP, Atassi G.
    Biochem Pharmacol; 1992 Nov 03; 44(9):1707-15. PubMed ID: 1360210
    [Abstract] [Full Text] [Related]

  • 5. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry.
    Sebille S, Morjani H, Poullain MG, Manfait M.
    Anticancer Res; 1994 Nov 03; 14(6A):2389-93. PubMed ID: 7825978
    [Abstract] [Full Text] [Related]

  • 6. Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.
    Merlin JL, Marchal S, Ramacci C, Dieterlen A, Schultz G, Lucas C, Poullain MG, Berlion M.
    Cytometry; 1995 Aug 01; 20(4):315-23. PubMed ID: 7587719
    [Abstract] [Full Text] [Related]

  • 7. [Quantitative cytological study of the activity of a new resistance modulator, S 9788, on human leukemic cells using multiparametric image analysis].
    Oum'Hamed Z, Berlion M, Millot-Broglio C, Dufer J, Joly P, Bizzari JP, Desplaces A.
    Bull Cancer; 1994 Mar 01; 81(3):203-11. PubMed ID: 7894128
    [Abstract] [Full Text] [Related]

  • 8. Multidrug resistance circumvention by a new triazinoaminopiperidine derivative S9788 in vitro: definition of the optimal schedule and comparison with verapamil.
    Julia AM, Roché H, Berlion M, Lucas C, Milano G, Robert J, Bizzari JP, Canal P.
    Br J Cancer; 1994 May 01; 69(5):868-74. PubMed ID: 8180016
    [Abstract] [Full Text] [Related]

  • 9. Effects of verapamil and S9788 on MDR-1 mRNA expression studied by in situ hybridization.
    Joly P, Lallemand A, Oum'Hamed Z, Trentesaux C, Idoine O, Desplaces A.
    Anticancer Res; 1996 May 01; 16(6B):3609-14. PubMed ID: 9042229
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro.
    Hill BT, van der Graaf WT, Hosking LK, de Vries EG, Mulder NH, Whelan RD.
    Int J Cancer; 1993 Sep 09; 55(2):330-7. PubMed ID: 8103761
    [Abstract] [Full Text] [Related]

  • 11. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT, Cirtain MC, Look AT, Ashmun RA.
    Cancer Res; 1986 Feb 09; 46(2):778-84. PubMed ID: 3455678
    [Abstract] [Full Text] [Related]

  • 12. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug 09; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 13. In vitro cytotoxicity of S16020-2, a new olivacine derivative.
    Léonce S, Perez V, Casabianca-Pignede MR, Anstett M, Bisagni E, Pierré A, Atassi G.
    Invest New Drugs; 1996 Aug 09; 14(2):169-80. PubMed ID: 8913838
    [Abstract] [Full Text] [Related]

  • 14. New purines and purine analogs as modulators of multidrug resistance.
    Dhainaut A, Regnier G, Tizot A, Pierre A, Leonce S, Guilbaud N, Kraus-Berthier L, Atassi G.
    J Med Chem; 1996 Sep 27; 39(20):4099-108. PubMed ID: 8831775
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
    Watanabe Y, Takano H, Kiue A, Kohno K, Kuwano M.
    Anticancer Drug Des; 1991 Feb 27; 6(1):47-57. PubMed ID: 2015041
    [Abstract] [Full Text] [Related]

  • 16. [Difference between the effects of S9788, verapamil and quinine on the reversion of multidrug resistance in two human tumor cell lines].
    Bennis S, Robert J.
    Bull Cancer; 1994 Oct 27; 81(10):886-90. PubMed ID: 7734772
    [No Abstract] [Full Text] [Related]

  • 17. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A, Seth K, Kalra N, Shukla Y.
    Toxicol Appl Pharmacol; 2005 Feb 01; 202(3):237-43. PubMed ID: 15667829
    [Abstract] [Full Text] [Related]

  • 18. Pervilleine F, a new tropane alkaloid aromatic ester that reverses multidrug resistance.
    Mi Q, Cui B, Lantvit D, Reyes-Lim E, Chai H, Pezzuto JM, Kinghorn AD, Swanson SM.
    Anticancer Res; 2003 Feb 01; 23(5A):3607-15. PubMed ID: 14666656
    [Abstract] [Full Text] [Related]

  • 19. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A.
    Toxicol In Vitro; 2008 Feb 01; 22(1):96-105. PubMed ID: 17920233
    [Abstract] [Full Text] [Related]

  • 20. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry].
    Belhoussine R, Morjani H, Manfait M.
    Bull Cancer; 1997 Apr 01; 84(4):343-9. PubMed ID: 9238156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.